HomeProductsBuilding BlocksHeterocyclic ScaffoldsPyrrolidinesTrv-120027
Chemical structure of CAS 1234510-46-3

Trv-120027

In Stock•Starting at $220 for 1 mg•Purity ≥ 99.46%
CAS No.1234510-46-3
MDL No.N/A
MFC43H67N13O10
MW926.10
InChI KeyXIEWFECSPPTVQN-KMIMAYJXSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
1 mg99.46%$220In Stock
5 mg99.46%$628In Stock
10 mg99.46%$995In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1234510-46-3
Product NameTrv-120027

Biological Targets

AGTR1

Associated Conditions

COVID-19·heart failure
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Distinct Mechanisms of β-Arrestin-Biased Agonist and Blocker of AT1R in Preventing Aortic Aneurysm and Associated Mortality.

Hypertension (Dallas, Tex. : 1979) • Vol. 80, Issue 2 • 2023
PMID: 36440576PMC: PMC9852074DOI: 10.1161/HYPERTENSIONAHA.122.19232

β-Arrestin-Biased Agonist Targeting the Brain ATR (Angiotensin II Type 1 Receptor) Increases Aversion to Saline and Lowers Blood Pressure in Deoxycorticosterone Acetate-Salt Hypertension.

Hypertension (Dallas, Tex. : 1979) • Vol. 77, Issue 2 • 2021
PMID: 33249862PMC: PMC7855825DOI: 10.1161/HYPERTENSIONAHA.120.15793

Biased ligand of the angiotensin II type 1 receptor in patients with acute heart failure: a randomized, double-blind, placebo-controlled, phase IIB, dose ranging trial (BLAST-AHF).

European heart journal • Vol. 38, Issue 30 • 2017
PMID: 28459958PMC: PMC5837312DOI: 10.1093/eurheartj/ehx196

First clinical experience with TRV027: pharmacokinetics and pharmacodynamics in healthy volunteers.

Journal of clinical pharmacology • Vol. 53, Issue 9 • 2013
PMID: 23813302DOI: 10.1002/jcph.111

Documentation

Similar Products